News & Events

Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials

by Insight Genetics
April 02, 2013

NCI—through the CADP—will support Insight Genetics by providing services of two CLIA-certified labs that will further validate the assay, access to clinical samples, subject matter expertise, and statistical consultation. This collaboration is the continuation of a successful relationship between NCI and Insight Genetics. In the last three years the molecular diagnostics company has been awarded four contracts from NCI for the development of companion diagnostics. 

Creating Companion Diagnostics with Biomarkers

by Mike May
February 15, 2013

For anyone wondering about a key pharmaceutical change, consider these words from JonEric Pettersson, manager of commercial development at Insight Genetics (Nashville, Tenn.): “Less than 1% of current drugs have a companion diagnostic, and 60% of the drugs in clinical trials have a companion diagnostic in mind.” He adds, “Companion diagnostics are an important component in moving the ball forward in personalized medicine.” Making those moves depends on biomarkers.

Insight Genetics Promotes Four

by Insight Genetics
February 11, 2013

Insight Genetics announces the promotion of four professionals who have been integral in the company’s growth in recent years and have made significant contributions to the advancement of personalized cancer care.

Insight Genetics: A Life Science Success Story

by CINDY SANDERS
February 04, 2013

Nashville Medical News profiles the progress of Insight Genetics following recent announcements pertaining to the continued globalization of its products. In addition to continuing its work with QIAGEN to expand access to reliable and efficient tests to identify cancer-causing mutations of anaplastic lymphoma kinase (ALK) in lung cancer, the Insight Genetics team is currently developing a test to expose a biomarker for triple negative breast cancer.  

Page 10 of 15 (72 items)

|< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 >|